| # | Drug | Count |
|---|---|---|
| 0 | PIOGLITAZONE | 86 |
| 1 | METFORMIN | 35 |
| 2 | METFORMIN ER 500 MG | 35 |
| 3 | METFORMIN ER 750 MG | 35 |
| 4 | MYCOPHENOLATE MOFETIL | 21 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 21 |
| 6 | INSULIN GLARGINE | 18 |
| 7 | PREDNISONE | 16 |
| 8 | TACROLIMUS | 16 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NOGAPENDEKIN ALFA INBAKICEPT-PMLN | 2 | 0.0408 |
| 1 | ERDAFITINIB | 3 | 0.0024 |
| 2 | PIOGLITAZONE | 86 | 0.0020 |
| 3 | BACILLUS CALMETTE-GUERIN | 3 | 0.0017 |
| 4 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 2 | 0.0016 |
| 5 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 6 | BISACODYL 5MG | 1 | 0.0011 |
| 7 | ENFORTUMAB VEDOTIN | 8 | 0.0010 |
| 8 | CALCIFEDIOL | 1 | 0.0004 |
| 9 | CABAZITAXEL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 39 |
| 1 | Insulin Analog [EPC] | 24 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 |
| 3 | Platinum-based Drug [EPC] | 19 |
| 4 | Benzodiazepine [EPC] | 16 |
| 5 | Sulfonylurea [EPC] | 15 |
| 6 | Proton Pump Inhibitor [EPC] | 14 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 9 | Opioid Agonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 3 | 0.0017 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 8 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |